The clinical effect of low molecular weight heparin in treatment of transient ischemic attack
Objective To observe the effect of low molecular weight heparin in treatment of transient ischemic attack (T1A) and the effect of it on coagulation indexes. Methods In the treatment group, T1A patients was treated with Subcutaneous injection of low molecular weight heparin calcium every 12 hours, and the platelet change and the INR change were observed, and the change of patients was compared with patients in the control group. Results In the treatment groups, the basic cure rate and the total effective rate were significantly higher than that of control group (P<0.01), and there were no obvious side effects, but BPT and INT had no significant difference) P>0. 05). Cod-clusion Low molecular weight heparin is a safe and effective drug in treatment of TIA.
NETL
NSTL
万方数据
维普
